Cargando…
Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies
Arthritic pathologies are a major cause of morbidity within the western world, with rheumatoid arthritis affecting approximately 1% of adults. This review highlights the therapeutic potential of naturally occurring hormones and their peptides, in both arthritic models of disease and patients. The ar...
Autores principales: | Getting, S. J., Kaneva, M., Bhadresa, Y., Renshaw, D., Leoni, Giovanna, Patel, H. B., Kerrigan, M. J. P., Locke, I. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823194/ https://www.ncbi.nlm.nih.gov/pubmed/20024514 http://dx.doi.org/10.1100/tsw.2009.163 |
Ejemplares similares
-
Annexin 1 and Melanocortin Peptide Therapy for Protection Against Ischaemic-Reperfusion Damage in the Heart
por: Gavins, F.N.E., et al.
Publicado: (2006) -
Glucocorticoid and Melanocortins: Special Issue
por: Getting, Stephen J.
Publicado: (2007) -
Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion
por: Leoni, Giovanna, et al.
Publicado: (2008) -
Activation of Melanocortin Receptors MC(1) and MC(5) Attenuates Retinal Damage in Experimental Diabetic Retinopathy
por: Rossi, S., et al.
Publicado: (2016) -
Corrigendum to “Activation of Melanocortin Receptors MC(1) and MC(5) Attenuates Retinal Damage in Experimental Diabetic Retinopathy”
por: Rossi, S., et al.
Publicado: (2021)